Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
3.5-Year trial tests Long-Term relief for debilitating skin condition
Disease control OngoingThis study aims to assess the long-term safety and effectiveness of nemolizumab, an injectable medication, for people with prurigo nodularis—a chronic skin disease causing intense itch and hard bumps. It will follow about 500 participants who previously took the drug in earlier s…
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Can a simple injection give you smoother, more radiant skin?
Symptom relief OngoingThis study is testing whether injections of a product called Restylane Skinboosters Vital can safely improve the quality of facial skin. About 171 Chinese adults with moderate to severe fine lines will receive either the injections or no treatment, and doctors will compare the re…
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC